LensCrafters Launches Vision & Eye Health Center, Integrated Ecosystem Includes Medical Services, Surgical Procedures

Published on June 30, 2026
NEW YORK—LensCrafters, part of EssilorLuxottica and a leading North American retail brand, today announces the launch of the first LensCrafters Vision & Eye Health Center, introducing premium comprehensive eyecare and surgical solutions in a modern, patient-centric environment. The center is located in Exton, Pa., and represents the first step within LensCrafters’ North American growth strategy, with the goal of “shaping the future of eye health and empowering people to reach their full potential through a holistic suite of vision care and surgical solutions made available under one roof,” the company said in an announcement.
Continue reading on website
Other news

Viridian Therapeutics Receives FDA Approval for Lumvoa for the Treatment of Thyroid Eye Disease (TED)

June 30, 2026
WALTHAM, Mass.—Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company, announced that the Food and Drug Administration (FDA) has approved Lumvoa (veligrotug-vvze) for the treatment of thyroid eye disease (TED). Lumvoa was approved by the FDA under priority review and supported by the THRIVE (active TED) and THRIVE-2 (chronic TED) pivotal phase 3 clinical trials. “With the approval of

Primary Eyecare Services rolls out referral management service in North West England

June 30, 2026
Helen Haslett, clinical triage lead, said: “At this scale, we have a real opportunity to transform how patients access eye care”